Characteristics of the population with mild COVID-19 symptoms eligible for early treatment attended in a single center in Northern Italy

After more than two years from the first COVID-19 detected case in Brescia, Northern Italy, monoclonal antibodies and antiviral therapy aimed at early treatment of mild COVID-19 in patients at risk of progression and of hospitalization has been approved in Italy. Here we report the characteristics o...

Descripción completa

Detalles Bibliográficos
Autores principales: Magro, Paola, Degli Antoni, M., Formenti, B., Viola, F., Castelli, F., Amadasi, S., Quiros-Roldan, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724552/
https://www.ncbi.nlm.nih.gov/pubmed/36521328
http://dx.doi.org/10.1016/j.jiph.2022.11.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724552/
https://www.ncbi.nlm.nih.gov/pubmed/36521328
http://dx.doi.org/10.1016/j.jiph.2022.11.027

Ejemplares similares